XML 69 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Data Segment Data - Revenues by Geographic Areas (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information [Line Items]      
Revenues $ 20,248 $ 17,117 $ 17,290
Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 9,479 8,680 9,064
Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 6,530 4,675 4,300
Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 4,239 3,762 3,926
United States      
Segment Reporting Information [Line Items]      
Revenues 10,969 9,716 9,730
United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 5,142 4,802 5,116
United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 2,980 2,337 1,931
United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 2,847 2,577 2,682
Non-US      
Segment Reporting Information [Line Items]      
Revenues 9,279 7,401 7,560
Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 4,336 3,878 3,947
Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 3,550 2,337 2,368
Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,392 1,186 1,244
Medication Delivery Solutions | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 4,057 3,555 3,848
Medication Delivery Solutions | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,246 1,972 2,037
Medication Delivery Solutions | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,812 1,583 1,811
Medication Management Solutions | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,432 2,454 2,640
Medication Management Solutions | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,863 1,865 2,115
Medication Management Solutions | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 570 589 525
Diabetes Care | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,160 1,084 1,110
Diabetes Care | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 606 562 573
Diabetes Care | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 554 522 538
Pharmaceutical Systems | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,829 1,588 1,465
Pharmaceutical Systems | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 428 404 392
Pharmaceutical Systems | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,401 1,184 1,073
Integrated Diagnostic Solutions | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 5,225 3,532 3,106
Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 2,477 1,872 1,446
Integrated Diagnostic Solutions | Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 2,748 1,659 1,659
Biosciences | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 1,305 1,143 1,194
Biosciences | United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 503 465 485
Biosciences | Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 802 678 709
Surgery | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,296 1,121 1,242
Surgery | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,023 891 977
Surgery | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 274 230 264
Peripheral Intervention | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,711 1,511 1,574
Peripheral Intervention | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 931 871 917
Peripheral Intervention | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 780 640 657
Urology and Critical Care | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,232 1,130 1,110
Urology and Critical Care | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 894 815 787
Urology and Critical Care | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues $ 338 $ 315 $ 323